Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synaptonemal Complex Analysis of Spermatocytes in Hybrids of Silver Fox and Blue Fox.

The Journal of heredity·2019
Same author

Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis.

Scandinavian journal of rheumatology·2019
Same author

Reduced display of conformational epitopes in the N-terminal truncated GAD65 isoform: relevance for people with stiff person syndrome or DQ8/8-positive Type 1 diabetes mellitus.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Pre-breeding survival of barnacle geese Branta leucopsis in relation to fledgling characteristics.

The Journal of animal ecology·2015
Same author

Doubly Reactive INS-IGF2 Autoantibodies in Children with Newly Diagnosed Autoimmune (type 1) Diabetes.

Scandinavian journal of immunology·2015
Same author

A pilot study on the feasibility of European harmonized human biomonitoring: Strategies towards a common approach, challenges and opportunities.

Environmental research·2015
Same journal

Fluoroquinolone Use and Risk of Pneumothorax in Adults Hospitalized With Community Acquired Pneumonia: A Retrospective Cohort Study.

The clinical respiratory journal·2026
Same journal

High-Flow Nasal Cannula in Hypercapnic Respiratory Failure: An Updated Systematic Review and Meta-Analysis.

The clinical respiratory journal·2026
Same journal

Self-Determined Motivation and Physical Activity in Chronic Obstructive Pulmonary Disease.

The clinical respiratory journal·2026
Same journal

Efficacy and Safety of Lianhua Qingke Tablets in Children With Mycoplasma pneumoniae Pneumonia: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Clinical Trial.

The clinical respiratory journal·2026
Same journal

Correction to "Risk Factors for the Recurrence of Massive Hemoptysis Treated With Bronchial Artery Embolization: A Retrospective Study".

The clinical respiratory journal·2026
Same journal

Clarifying Terminology in Chronic Cough: The Evolving Role of Cough Hypersensitivity Syndrome.

The clinical respiratory journal·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Inflammatory markers in COPD.

K Larsson1

  • 1Unit of Lung and Allergy research, Ntauional Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. kjell.larsson@ki.se

The Clinical Respiratory Journal
|March 20, 2010
PubMed
Summary
This summary is machine-generated.

Chronic obstructive pulmonary disease (COPD) involves airway and systemic inflammation. Key inflammatory mediators like IL-8 and LTB4 drive neutrophilic responses, while blood markers offer insights into systemic effects and comorbidities.

Related Experiment Videos

Last Updated: Jun 14, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Biomarker Research

Background:

  • Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disorder with systemic multi-organ involvement.
  • Inflammation in COPD affects airways and lung tissue, involving various immune cells and mediators.
  • Understanding these inflammatory pathways is crucial for managing COPD and its associated conditions.

Purpose of the Study:

  • To review the inflammatory mechanisms and mediators involved in COPD.
  • To explore methods for monitoring inflammation in COPD, including airway and systemic markers.
  • To discuss the potential of blood-based biomarkers for understanding systemic manifestations and comorbidities.

Main Methods:

  • Review of scientific literature on COPD inflammation.
  • Analysis of inflammatory mediators such as cytokines and chemoattractants (e.g., IL-8, LTB4, CCL2, CCL3).
  • Evaluation of different monitoring techniques: bronchoalveolar lavage, sputum, exhaled air/condensate, blood, urine, and tissue samples.

Main Results:

  • Neutrophilic granulocytes, attracted by IL-8 and LTB4, are key inflammatory players.
  • Macrophages and T-lymphocytes (CD8+) also contribute significantly to COPD inflammation.
  • Blood markers like IL-6, CRP, and fibrinogen show promise for understanding systemic involvement and cardiovascular comorbidities.

Conclusions:

  • Inflammation is central to COPD pathogenesis, involving complex interactions of immune cells and mediators.
  • While airway analyses have limitations, blood markers offer a promising avenue for assessing systemic inflammation and comorbidities in COPD.
  • Further research into blood biomarkers could enhance the understanding and management of COPD, particularly its cardiovascular links.